Metraipolis › archive › dc_e8dae5d89ed2
Predicting Outcomes and Optimizing Therapy in Thrombotic Thrombocytopenic Purpura: Insights on Caplacizumab Use from a Romanian Hematology Center — Europe PMC PMID:41303245
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41303245
- DOI
- 10.3390/jcm14228211
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T10:16:24.544Z
- SHA-256 of the archived text
2f32a658e28f21b16bc60a57275a8ef45a5716d880d2f184be7f8ed9d5fcd4b0- Stable URL of this page
https://metraipolis.com/documento/dc_e8dae5d89ed2
How to cite
Predicting Outcomes and Optimizing Therapy in Thrombotic Thrombocytopenic Purpura: Insights on Caplacizumab Use from a Romanian Hematology Center — Europe PMC PMID:41303245 — Europe PMC (en), https://europepmc.org/article/MED/41303245 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e8dae5d89ed2 (Metraipolis archive dc_e8dae5d89ed2, sha256 2f32a658e28f21b16bc60a57275a8ef45a5716d880d2f184be7f8ed9d5fcd4b0)
BibTeX
@misc{dce8dae5d89ed2,
title = {Predicting Outcomes and Optimizing Therapy in Thrombotic Thrombocytopenic Purpura: Insights on Caplacizumab Use from a Romanian Hematology Center — Europe PMC PMID:41303245},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41303245},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e8dae5d89ed2; sha256 2f32a658e28f21b16bc60a57275a8ef45a5716d880d2f184be7f8ed9d5fcd4b0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303245. Agents can read the archived copy with the MCP tool read_document.